$TCBP to Present at the 2024 #ThinkEquity Conference in NYC on October 30, 2024, at the Mandarin Oriental Hotel finance.yahoo.com/news/tcbp-pres…

$TCBP Announces #Site #Opening of Guys and St. Thomas Hospital prnewswire.com/news-releases/…

$TCBP Announces #ArtificialIntelligence Initiative with Partner Carnegie Mellon University for Donor Screening ir.tcbiopharm.com/news/press-rel…

in August, continued strength in the #stock and operationally advancing out Phase 2B trial rapidly with extensive good news in partnerships with leading institutions like Carnegie Mellon University. We must be doing something right for these types of desperate measures to be taken.

$TCBP is in no way out of compliance or at any risk of delisting from the Nasdaq Exchange This type of fake news is spread by nefarious actors with motives to drive the stock down. it is directly in contradiction to the obvious success of TC BioPharm's strong fundamental raise

$TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for #Mpox Therapeutic ir.tcbiopharm.com/news/press-rel…

In the wake of #False #Tweets causing our share price to drop precipitously, I have purchased shares in the open market showing my commitment and firm belief in $TCBP & our goal of data in 1H 2025. This is on top of the prior shares I chose to take in place of cash compensation.

$TCBP Awarded Non-Dilutive Funding, Scaleready's G-Rex® $Grant #celltherapy #oncology ir.tcbiopharm.com/news/press-rel…

Congrats to Poseida Therapeutics on being acquired by Roche. After such a long freeze, it's great to see M&A activity in the Cell Therapy Space. prnewswire.com/news-releases/…

$TCBP appreciates being a part of the great work from the team Cell and Gene Therapy Catapult #CellTherapy Read the Report Here: cgt.ams3.cdn.digitaloceanspaces.com/GMP-Manufactur…

$TCBP Advances ACHIEVE Phase 2b Clinical Trial with #Final #Dosing of 3 Patients finance.yahoo.com/news/tcbp-adva…

$TCBP Provides Update on #Acquisition Strategy and Current Targets finance.yahoo.com/news/tcbp-prov…

I'm looking forward to attending the J.P. Morgan Healthcare Conference Jan. 13-16th in #SanFrancisco. jpmorgan.com/about-us/event…

$TCBP shareholders, As stated in our 6k, the Company intends to appeal the notice to the Nasdaq Panel. This follows the same process we previously followed when receiving these notices from Nasdaq when we were in deficiency status.

$TCBP Announces #H5N1 Proof of Concept Studies Intention finance.yahoo.com/news/tcbp-anno…

benzinga.com/general/biotec…

$TCBP Bryan Kobel to Participate on Cancer Progress Panel at 18th Annual European Life Sciences CEO Forum finance.yahoo.com/news/tcbp-ceo-…

$TCBP Announces Non-Binding Letter of Intent to #Acquire #Commercial #Stage Ophthalmic Pharmaceutical Company finance.yahoo.com/news/tcbp-anno…

$TCBP Announces Outsourcing Initiatives, Reducing Burn Rate and Overhead The company is expected to reduce core operational burn by 55% when compared to 2024 ir.tcbiopharm.com/news/press-rel…

$TCBP Announces Grant of European #Patent for Targeting of Microbial, #Oncological, and Viral Indications using Modified Gamma Delta T Cells finance.yahoo.com/news/tcbp-anno…